Douglas Kerr
Equibles does not estimate personal net worth.
Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DYN alertsAbout Douglas Kerr
The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $1,057,598 for Douglas Kerr in fiscal 2025, including a base salary of $537,000. Disclosed compensation is on record for 2 fiscal years. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John G. Cox (CEO and Board Member), Josh Brumm (CEO), Erick Lucera (CFO and Chief Accounting Officer) and 4 others.
Affiliation history
-
Dyne Therapeutics, Inc. (DYN)
Proxy statement
CurrentStart not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Dyne Therapeutics, Inc.
- John G. Cox CEO, Board Member
- Josh Brumm CEO
- Erick Lucera CFO, Chief Accounting Officer
- Barry E. Greene Board Member
- Brian Posner Board Member
- Carlo Incerti, M.D. Board Member
- Vikram Karnani Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | $537,000 | $1,057,598 |
| 2024 | Dyne Therapeutics, Inc. (DYN) | Chief Medical Officer | $172,795 | $7,741,647 |
Recent activity
No call appearances or filed executive changes recorded yet.